Cargando…
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
INTRODUCTION: Patients undergoing immunosuppressive therapy are at increased risk of infection. Community-acquired pneumonia and invasive pneumococcal disease account for substantial morbidity and mortality in this population and may be prevented by vaccination. Ideally, immunization to pneumococcal...
Autores principales: | Fischer, Lara, Gerstel, Patricia Francis, Poncet, Antoine, Siegrist, Claire-Anne, Laffitte, Emmanuel, Gabay, Cem, Seebach, Joerg Dieter, Ribi, Camillo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481118/ https://www.ncbi.nlm.nih.gov/pubmed/26048579 http://dx.doi.org/10.1186/s13075-015-0663-9 |
Ejemplares similares
-
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) in Adults with and without Immunosuppressive Therapy
por: Garcia Garrido, Hannah M., et al.
Publicado: (2022) -
Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020) -
The effect of age on the response to the pneumococcal polysaccharide vaccine
por: Lee, Hyunju, et al.
Publicado: (2010) -
Pneumococcal vaccination of older adults: Conjugate or polysaccharide?
por: Hollingsworth, Rosalind, et al.
Publicado: (2014) -
Pneumococcal Polysaccharide Vaccine Ameliorates Murine Lupus
por: Cantarelli, Chiara, et al.
Publicado: (2019)